tirzepatide surpass Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial 💡 New insight in diabetes

If your prescription is written for a brand, comparing it to the generic (and to other rescue inhalers) can help you find the best price

Because semaglutide slows down digestion, jumping straight to a high dose could cause significant discomfort, such as nausea or stomach upset

Pathogens, such as viruses or bacteria, can cause pancreatitis.[ref] Drugs or toxins can also trigger pancreatitis

The medication reduces appetite drive, but willpower, food environment, and habit patterns still matterespecially as you approach your goal weight, where the appetite-suppressing effect becomes less dramatic

The question of semaglutide safety in patients with ulcerative colitis requires careful consideration